Brief Article
Journal of Medicinal Chemistry, 2010, Vol. 53, No. 18 6767
group. Elevated MDA levels in plasma and lung suggested
decreased levels of endogenous antioxidants and indicated that
7 significantly attenuated downstream lipid peroxidation and
cellular injury. This beneficial effect might be partly related to
the antioxidant and scavenging capacities of 7 for reactive •OH
and H2O2 species.
Acknowledgment. The authors are grateful to NASA
(Grant MSGC R85197), Research Excellence Fund (Grant
R01121), Natural Science Foundation of HeBei, China (Grant
062761266), and the Administration of Traditional Chinese
Medicine of HeBei Province (Grant 2007134) for support
of this research. The authors are also grateful to Professor
Hualiang Jiang for many helpful suggestions.
During hind limb ischemia/reperfusion, leukocytes may
reenter the systemic circulation. These activated neutrophils
may cause local and remote organ damage, especially in the
lungs. After adhering to the pulmonary microvascular en-
dothelium, neutrophils exert their toxic effects through the
release of proteolytic enzymes and free radicals.2 We found
that lung MPO activity in the I/R injury group was signifi-
cantly increased (Table5, see Supporting Information). Treat-
ment with 7 significantly attenuated this effect. The decrease
in lung MPO activity and attenuation of lung histopathology
(Figure 4D-F) indicated that 7 could protect the remote
organ (lung) against limb I/R injury. This protectiveeffect of7
most likely resulted from an inhibition of neutrophil infiltra-
tion and lipid peroxidation. This proposed inhibition is also
associated with tissue edema as evaluated by the W/D ratio
(wet to dry tissue weight ratio) (Table 6, see Supporting
Information), which revealed that 7 was effective at attenuat-
ing the lung damage associated with limb I/R injury.
Skeletal muscle ischemia is associated with an increase in
vascular permeability, which is characterized by swollen and
edematous muscle after acute limb injury. Our histological
results (Figure 3A-C) revealed a significant separation be-
tween muscle fiber bundles, suggesting the presence of inter-
stitial edema and increased microvascular permeability.
Microvascular permeability is an indicator of skeletal muscle
injury following hind limb I/R. As for other parameters
measured, this muscle edema was significantly attenuated
with 7 treatment (Figure 3D-F). As well, signs of pulmonary
edema consisting of interstitial thickening and a high degree of
neutrophil infiltration in the lung capillary vessels and inter-
stitium (Figure 4A-C) was vastly improved following inter-
vention with 7 (Figure 4D-F). The histological results further
confirmed that 7 could reduce the tissue edema and protect
local and remote organ against hind limb I/R injury. We
speculate that the efficacy in protection for indole deriva-
tive 7 against local and remote organ injury results from the
combined effects of inhibiting the release of free radicals and
proinflammatory cytokines.
Supporting Information Available: Details of the synthetic
procedures and characterization for 1-10 and details of biolo-
gical tests. This material is available free of charge via the
References
(1) Eliason, J. L.; Wakefield, T. W. Metabolic consequences of acute
limb ischemia and their clinical implications. Semin. Vasc. Surg.
2009, 22, 29–33.
(2) Blaisdell, F. W. The pathophysiology of skeletal muscle ischemia
and the reperfusion syndrome: a review. Cardiovasc. Surg. 2002, 10,
620–630.
(3) (a) Lakhan, S. E.; Kirchgessner, A.; Hofer, M. Inflammatory
mechanisms in ischemic stroke: therapeutic approaches. J. Transl.
Med. 2009, 7, 97–107. (b) Walsh, K. B.; Toledo, A. H.; Rivera-Chavez,
F. A.; Lopez-Neblina, F.; Toledo-Pereyra, L. H. Inflammatory mediators of
liver ischemia-reperfusion injury. Exp. Clin. Transplant. 2009, 7, 78–93.
ꢁ
(4) Rodrıguez, A. D.; Gonzalez, P. A. Ischemia-reperfusion injury
´
and melatonin. Rev. Esp. Cardiol. 2009, 62, 952–953.
(5) Jiang,J.B.;Johnson,M.G.;Nichols, J. 1,3-Dioxane Derivatives Having
Protein Kinase C Inhibitory Activity. U.S. Patent 5,360,818, 1994.
(6) (a) Bi, L.; Zhao, M.; Gu, K.; Wang, C.; Ju, J.; Peng, S. Toward the
development of chemoprevention agents (III): synthesis and anti-
inflammatory activities of a new class of 5-glycylamino-2-substituted-
phenyl-1,3-dioxacycloalkanes. Bioorg. Med. Chem. 2008, 16, 1764–
1774. (b) Bi, L.; Zhang, Y.; Zhao, M.; Wang, C.; Tok, J.; Peng, S. Novel
synthesis and anti-inflammatory activites of 2,5-disubstituted-dioxacy-
cloalkanes. Bioorg. Med. Chem. 2005, 13, 5640–5646. (c) Gu, K.; Bi,
L.; Zhao, M.; Wang, C.; Ju, J.; Peng, S. Toward the development of
chemoprevention agents. Part 1: Design, synthesis, and anti-inflammatory
activities of a new class of 2,5-disubstituted-dioxacycloalkanes. Bioorg.
Med. Chem. 2007, 15, 4775–4799. (d) Gu, K.; Bi, L.; Zhao, M.; Wang, C.;
Ju, J.; Peng, S. Toward the development of chemoprevention agents.
Part II: Chemo-enzymatic synthesis and anti-inflammatory activities of a
new class of 5-amino-2-substituted phenyl-1,3-dioxacycloalkanes. Bioorg.
Med. Chem. 2007, 15, 6273–6290. (e) Gu, K.; Bi, L.; Zhao, M.; Wang, C.;
Tok, J.; Peng, S. Stereoselective synthesis and anti-inflammatory activity of
5-amino-2-(2,2-dimethoxyethyl)-1,3-dioxacycloalkanes. Bioorg. Med.
Chem. 2006, 14, 1339–1347.
(7) Cano, A.; Alcaraz, O.; Arnao, M. B. Free radical-scavenging
activity of indolic compounds in aqueous and ethanolic media.
Anal. Bioanal. Chem. 2003, 376, 33–37.
(8) Berenbaum, F. Free radicals and inflammation. Ann. Rheum. Dis.
2001, 60, 442.
(9) Winter, C. A.; Risley, E. A.; Nuss, G. W. Carrageenin-induced
edema in hind paw of the rat as an assay for antiiflammatory drugs.
Proc. Soc. Exp. Biol. Med. 1962, 111, 544–547.
Conclusion
We have designed and synthesized several related indole
derivatives with particular focus on the methoxy group, the
indole heterocycle, and the spatial composition. The antiin-
flammatory activities of all newly synthesized indole derivatives
3-10 were examined in the xylene-induced ear edema murine
model and the carrageenan-induced paw inflammation model
in the rat. The potent radical scavenging activity of 7 and 9 was
examined in rat pheochromocytoma (PC12) cell survival assays,
this cell line being exquisitely sensitive to free radical damage.
Considering its superior antiinflammatory and antioxidant
capacity, 7 was further evaluated in a hind limb I/R injury
animal model, which revealed its significant capacity to reduce
lipid peroxidation and local (muscle) and remote organ (lung)
injury induced by hind limb I/R injury in rats. These findings
suggest that indole derivative 7 may become an important agent
to attenuate the severity of I/R injury for future investigations,
although the precise cellular mechanism of action for this
compound remains to be determined.
(10) (a) Hillion, J.; Takahashi, K.; Maric, D.; Ruetzler, C.; Barker, J.;
Hallenbeck, J. Development of an ischemic tolerance model in a
PC12 cell line. J. Cereb. Blood Flow Metab. 2005, 25, 154–162.
(b) Bi, W.; Bi, L.; Cai, J.; Liu, S.; Peng, S.; Fischer, N.; Tok, J.; Wang, G.
Dual-acting agents that possess free radical scavenging and antithrom-
botic activities: design, synthesis, and evaluation of phenolic tetrahy-
dro-β-carboline RGD peptide conjugates. Bioorg. Med. Chem. Lett.
2006, 16, 4523–4527. (c) Bi, W.; Cai, J.; Liu, S.; Baudy-Floch, M.; Bi,
L. Design, synthesis and cardioprotective effect of a new class of dual-
acting agents: phenolic tetrahydro-β-carboline RGD peptidomimetic
conjugates. Bioorg. Med. Chem. 2007, 15, 6909–6919. (d) Wu, Y.; Bi,
L.; Bi, W.; Li, Z.; Zhao, M.; Wang, C.; Ju, J.; Peng, S. Novel
2-substituted nitronyl nitroxides as free radical scavengers: synthesis,
biological evaluation and structure-activity relationship. Bioorg. Med.
Chem. 2006, 14, 5711–5720.
(11) Lavarda, F. C. Relation between antioxidant activity and electro-
nic structure of phenols. Iny. J. Quantum Chem. 2003, 95, 219–
223.
(12) Beuge, J. A.; Aust, S. D. Microsomal lipid peroxidation. Methods
Enzymol. 1978, 52, 302–311.
(13) Hillegass, L. M.; Griswold, D. E.; Brickson, B.; Albrightson-
Winslow, C. Assessment of myeloperoxidase activity in whole rat
kidney. J. Pharmacol. Methods 1990, 24, 285–295.